$RYTM

$87.53▲ -2.5% YTD

4 SEC 13D/G filings tracked · Last updated Oct 13, 2026

Filing History

RYTM ▼ -2.5% - Rhythm Pharmaceuticals, Inc.

CP $87.53▲ -2.5%Oct 13, 2026 · ThinkSabio Blog

$RYTM - Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity…

SEC 13D/G

RYTM - Rhythm Pharmaceuticals, Inc. - SEC Filing Update (13-OCT-2026) | ThinkSabio - Stocks Simplified

$87.47▼ -16.77%Oct 13, 2026 · ThinkSabio Blog

$RYTM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #RYTM Rhythm Pharmaceuticals, Inc. : $87.47 Sector: Healthcare |…

News

RYTM ▼ -0.0% - Rhythm Pharmaceuticals, Inc.

CP $98.82▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$RYTM - Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 y…

News

RYTM ▲ +0.4% - Rhythm Pharmaceuticals, Inc.

CP $101.49▲ +0.4%Sep 10, 2026 · ThinkSabio Blog

$RYTM - Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting…